Related by context. Frequent words. (Click for all words.) 57 Trades +#.# % 56 Trades -#.# 54 MidnightTrader.com 54 NASDAQ CRXL 53 Crucell NV Euronext 52 TARRYTOWN NY BUSINESS WIRE 52 CHF#.# [005] 52 By TIM BROUK 52 See BioWorld Today 52 EXTON Pa. BUSINESS WIRE 52 volatility Elevated 51 By CURT SLYDER 51 Qiagen NV 51 SEK#.# [001] 51 Actelion Ltd 51 By Melody Brumble 51 NOK#.# [003] 51 Turnover amounted 51 Tellabs NASDAQ TLAB 51 CHATSWORTH Calif. BUSINESS WIRE 51 By SOPHIA VORAVONG 51 WILSONVILLE Ore. BUSINESS WIRE 51 EST Related Symbols 51 EZCH 50 NASDAQ ASMI 50 NowPublic Staff 50 Jordan Yerman 50 EURO CDS 50 Communiqué de presse 50 By Miya Knights 50 SXDP 50 MUNICH Germany BUSINESS WIRE 50 • dcastell@visalia.gannett.com • 50 LYON France BUSINESS WIRE 50 By Weston Hodkiewicz 50 Navios Maritime Partners 50 日 の マニラ 新聞 50 から 50 NTQ 50 • SeanDuff@coloradoan.com • 50 ARGUS • 50 Advanced Analogic 50 • vwelborn@gannett.com • 50 #.# pence valuing 49 EDT Related Symbols 49 SMART Modular Technologies WWH 49 NASDAQ SWIR 49 DIAGNOS inc 49 Nasdaq Adv Dec 49 CHF#.# [006] 49 Jessica Geen • 49 SEK#.# [003] 49 #-#/# pence valuing [002] 49 NORCROSS Ga. BUSINESS WIRE 49 MCRL 49 QIAGEN NV 49 On Orbit Status 49 HORSHAM Pa. BUSINESS WIRE 49 BY TREVOR HUGHES 49 David Brauer Published 49 By Andy Nelesen 49 #/shr 49 Dollar Tree NASDAQ DLTR 49 Nasdaq CEVA 49 美 通 社 49 NASDAQ ZRAN 49 Staff Writer PinkNews.co.uk • 49 ENZN 49 OYJ 49 By Asavin Wattanajantra 49 APMonday 49 VICL 49 Siemens Aktiengesellschaft 49 BOTHELL Wash. BUSINESS WIRE 49 IDXX 49 SET TO REBOUND AFTER 49 By DOUG ZALESKI 49 TECD 48 Integrated Device 48 REPORT ITS QUARTERLY 48 FinancialWire via COMTEX 48 By Times.am 48 MXIM 48 AVGO 48 By MIKE CARMIN 48 NEWTOWN Pa. BUSINESS WIRE 48 Cyclacel Pharmaceuticals 48 Betty Verdun published 48 WILL BE REPORTED IN 48 BASINGSTOKE England 48 By Chris Umpierre 48 BEDFORD Mass. BUSINESS WIRE 48 ASML Holding 48 SHARES UP 48 SANTA CLARA CALIF 48 PRESS DIGEST Malaysia 48 http:/www.schaeffersresearch.com/wire?ID=# [001] 48 HAYWARD Calif. BUSINESS WIRE 48 SDTH 48 Clinical Trials Update 48 Persbericht